Tonometry Clinical Guide
Comprehensive intraocular pressure measurement protocols, interpretation thresholds, and referral pathways for clinical optometric practice.
Last updated: March 2026
Clinical Guide Overview
- 1. Clinical Importance
- 2. Equipment and Tools
- 3. Patient Preparation
- 4. GAT Protocol
- 5. NCT Protocol
- 6. Rebound Protocol
- 7. Tono-Pen Protocol
- 8. CCT & IOP Correction
- 9. Interpreting IOP Results
- 10. Management & Referral Thresholds
- 11. Special Populations
- 12. Clinical Pearls and Best Practices
- Quick Reference Protocol
- Documentation and Communication
- References
1. Clinical Importance
Tonometry is the clinical measurement of intraocular pressure (IOP) — the fluid pressure within the eye generated by the balance between aqueous humour production and drainage. It is an essential component of every comprehensive eye examination and the cornerstone of glaucoma detection and monitoring.
Elevated IOP is the principal modifiable risk factor for glaucomatous optic neuropathy. While glaucoma can occur at normal IOP levels (normal tension glaucoma), and elevated IOP does not always cause glaucoma (ocular hypertension), IOP measurement guides diagnosis, treatment decisions, and monitoring of the vast majority of glaucoma patients worldwide.
Optometrists are the primary providers of IOP measurement in community eye care globally. Accurate, consistent tonometry — combined with disc assessment, visual fields, and OCT — forms the basis of effective glaucoma case detection and long-term management.
| IOP Range (mmHg) | Classification | Clinical Implication |
|---|---|---|
| <10 | Hypotony | Wound leak, cyclodialysis, over-treated glaucoma — investigate |
| 10–21 | Normal range | Statistically normal (population mean ~15.5 ± 2.5 mmHg) |
| 22–24 | Borderline / OHT | Monitor carefully; assess disc, CCT, VF; consider referral |
| ≥25 | Ocular hypertension (OHT) | Refer for glaucoma evaluation; treatment threshold varies by jurisdiction |
| ≥30 | Significantly elevated | High glaucoma risk; urgent referral; consider same-day if symptomatic |
| ≥35 with symptoms | Possible acute angle closure | Emergency referral — rule out acute angle-closure glaucoma |
Anatomy & Physiology of IOP
Aqueous Humour Dynamics
IOP is determined by the balance between aqueous humour production and drainage. Disruption of either process leads to abnormal IOP.
- Production: Aqueous humour is produced by the ciliary body epitheliumvia active secretion (70–80%), ultrafiltration (~20%), and diffusion (~5%). Normal production rate: approximately 2–3 µL/min.
- Drainage — trabecular (conventional) pathway (80–90%): Aqueous flows from the posterior chamber through the pupil → anterior chamber → trabecular meshwork → Schlemm's canal → collector channels → episcleral veins. This is the pressure-sensitive pathway targeted by most glaucoma medications and laser treatments.
- Drainage — uveoscleral (unconventional) pathway (10–20%): Aqueous passes through the ciliary muscle bundles into the supraciliary and suprachoroidal space and drains through the sclera. Prostaglandin analogues primarily increase this pathway.
- Episcleral venous pressure (EVP): Normal EVP ~8–10 mmHg. Elevated EVP (Sturge-Weber syndrome, carotid-cavernous fistula, superior vena cava obstruction) raises IOP independent of trabecular resistance.
Factors Affecting IOP
Physiological Variables
- Diurnal variation: IOP typically highest in the early morning (6–8 am) and lowest in the evening. Fluctuation 3–6 mmHg in normal eyes; up to 10+ mmHg in glaucoma.
- Age: IOP increases slightly with age due to reduced trabecular outflow facility.
- Posture: IOP increases by ~1–2 mmHg on moving from sitting to supine (relevant for nocturnal IOP spikes in NTG).
- Valsalva / breath holding: Transient IOP elevation.
- Systemic blood pressure: Mild positive correlation.
- Caffeine: Mild transient increase. Exercise: acute decrease.
Measurement Artefacts
- Central corneal thickness (CCT): Thin corneas underestimate IOP; thick corneas overestimate (Goldmann assumes 520 µm).
- Corneal curvature: Steep corneas slightly overestimate; flat corneas underestimate.
- Corneal rigidity / biomechanics: Affects GAT and NCT results. ORA and Corvis ST provide biomechanically corrected IOP.
- Lid squeezing: Increases IOP during measurement.
- Contact lens wear: Can affect corneal biomechanics; measure after lens removal.
- Fluorescein concentration: Affects mire width and GAT accuracy.
2. Equipment and Tools
Comparison of Tonometry Instruments
| Instrument | Principle | Accuracy | Anaesthetic Required | Best Use |
|---|---|---|---|---|
| Goldmann Applanation (GAT) | Applanation (Imbert-Fick law) | Gold standard | Yes | Slit lamp; routine clinical standard |
| Non-Contact (NCT / Air Puff) | Air pulse deformation | Screening; ±2–3 mmHg vs GAT | No | Screening, children, anxious patients |
| Rebound (iCare) | Probe rebound deceleration | Good; comparable to GAT at normal IOP | No | Children, domiciliary, self-tonometry |
| Tono-Pen | Micro-applanation (strain gauge) | Moderate; useful for irregular corneas | Yes | Irregular/oedematous cornea, post-keratoplasty |
| Perkins | Applanation (hand-held GAT) | Comparable to GAT | Yes | Supine patients, children under GA, domiciliary |
| Ocular Response Analyser (ORA) | Corneal hysteresis (dynamic) | Biomechanically corrected IOPcc | No | Glaucoma suspects; biomechanical assessment |
| Corvis ST | Scheimpflug + air pulse | bIOP (biomechanically corrected) | No | Research; pre-refractive surgery; ectasia risk |
Infection Control & Instrument Maintenance
- GAT prism sterilisation: After each patient, clean the applanation prism with a fresh alcohol (isopropyl 70%) wipe and allow to air-dry for 5 minutes. Alternatively, use single-use disposable prism covers (e.g., Tonosafe). Full soaking in 1:10 sodium hypochlorite for 10 minutes is required for patients with known adenoviral conjunctivitis or suspected CJD. Rinse thoroughly with sterile saline after chemical disinfection to prevent corneal toxicity.
- iCare probes: Single-use disposable probes only. Never reuse. Check probe loading before each measurement.
- NCT: Non-contact; no direct corneal touch. Clean air puff nozzle and chin rest with disinfectant wipe between patients.
- Calibration: GAT should be verified against the calibration bar supplied with the instrument at the start of each clinical session. Replace the applanation prism if the calibration reading is outside ±0.5 mmHg.
3. Patient Preparation
General Preparation (All Methods)
- Contact lens removal: Ask the patient to remove soft contact lenses before tonometry. Contact lenses alter corneal biomechanics and can be damaged or contaminated. Hard (RGP) lenses should also be removed and a 20–30 minute wait is ideal before measuring IOP.
- Order of tests: Perform tonometry before corneal staining or slit lamp examination where possible to avoid epithelial disruption affecting the reading. If dilation is planned, measure IOP before instilling mydriatics.
- Explain the procedure: Briefly describe what the patient will feel (a puff of air, light touch, or slight pressure) depending on the method. Patient cooperation and minimal blinking are essential for accuracy.
- Seated position: For slit lamp GAT, ensure the patient is seated comfortably with the chin and forehead resting firmly in the headrest. The patient's outer canthus should be aligned with the canthus marker on the slit lamp.
- Avoid lid squeezing: Instruct patient to keep eyes wide open and look at the fixation target. Eyelid squeezing artificially raises IOP. If necessary, gently hold the upper and lower lids apart with your fingers — but avoid applying pressure to the globe.
Topical Anaesthetic & Fluorescein (GAT)
- Anaesthetic options:
- Oxybuprocaine (benoxinate) 0.4%: Most commonly used for tonometry. Onset 30–60 seconds; duration ~15–20 minutes. Minimal stinging.
- Proxymetacaine (proparacaine) 0.5%: Minimal sting on instillation. Preferred for patients who find oxybuprocaine uncomfortable.
- Tetracaine 0.5%: Longer duration; more stinging on instillation. Generally not preferred for routine tonometry.
- Minims (single-dose units): Use a fresh Minim for each patient to prevent contamination.
- Fluorescein application: Use a fluorescein-impregnated strip (e.g., Fluoret) or combined fluorescein + anaesthetic drops (e.g., Minims Fluorescein + Benoxinate). Touch the moistened strip to the lower conjunctival fornix — do not touch the cornea. Instruct patient to blink twice to distribute the fluorescein.
- Wait time: Allow 30–60 seconds after instillation for anaesthesia to take full effect before beginning GAT.
- Fluorescein concentration: Excess fluorescein (bright orange, thick tears) causes the mires to appear too wide, giving a falsely high IOP reading. Insufficient fluorescein (thin mires) gives a falsely low reading. The correct endpoint is a clear, faint blue-green ring. If mires are too bright/wide, ask the patient to blink once or two before remeasuring.
Contraindications & Precautions
- Active corneal ulcer or open globe: Do not perform contact tonometry (GAT, Tono-Pen). Use NCT only if clinically necessary — ideally defer.
- Known allergy to local anaesthetics: Use rebound tonometry (iCare) or NCT as no anaesthetic is required.
- Fluorescein allergy (rare): Use non-fluorescein methods (NCT, iCare, Tono-Pen).
- Recent corneal surgery (LASIK/PRK within 3 months): All contact methods may be inaccurate; use NCT or iCare with caution; note on records.
- Herpes simplex keratitis: Exercise caution with contact tonometry; consider iCare with strict single-use probe disposal and instrument disinfection.
- Nystagmus / unable to maintain fixation: GAT technically difficult; iCare or NCT preferred.
4. GAT Protocol
Principle (Imbert-Fick Law)
GAT is based on the Imbert-Fick law: P = F / A, where P = IOP, F = the force required to flatten (applanate) a known area of the cornea, and A = the applanated area. The Goldmann prism applanates a 3.06 mm diameter circular area of the cornea. At this specific area, the surface tension of the fluorescein tear film (which would pull the prism towards the cornea) exactly balances the corneal rigidity (which resists applanation), theoretically cancelling both forces. The result is a direct measurement of IOP from the applied force alone.
Setup & Calibration
- Calibrate the tonometer: Place the calibration bar over the prism holder. The pointer should deflect to each of the three positions (0, 2, 6 on the bar) when the drum is set to 0, 20, and 60 mmHg respectively. If outside ±0.5 mmHg, the instrument requires servicing.
- Clean the prism: Wipe with 70% isopropyl alcohol wipe. Allow to dry completely — residual alcohol on the prism will sting the patient and affect the tear film.
- Set the drum to 1 (10 mmHg): Starting at 10 mmHg avoids discomfort from excessive pressure if the IOP is low.
- Align the prism: Set the prism to 0° (or 43° if astigmatism >3DC — see pearl below). The red mark on the prism holder aligns with the white mark at 0°.
- Set cobalt blue filter and low illumination: Set the slit lamp illumination to maximum with the cobalt blue filter to excite fluorescein. Set the slit to a wide beam, no aperture. Angle the illumination approximately 60° from the observation axis.
Measurement Procedure
- Instil anaesthetic and fluorescein as described in Section 3. Wait 30–60 seconds.
- Position the patient at the slit lamp with chin and forehead firmly in the headrest. Align outer canthus with the canthus marker. Ask the patient to fixate a target in the distance with the fellow eye if possible.
- Advance the prism towards the cornea using the joystick. Approach from slightly below to avoid touching the upper lashes. Watch from the side initially to judge proximity — do not look through the eyepieces until close.
- Make contact: As the prism touches the cornea, two blue-green semicircular mires will appear in the viewing field. The mires are the fluorescein rings formed at the upper and lower edges of the applanated tear film, bisected horizontally by the prism biprism optics.
- Adjust the drum until the inner edges of the two mires just touch:
- If the mires overlap (inner edges cross) → IOP reading is too high → reduce drum.
- If the mires are separated (gap between inner edges) → IOP reading is too low → increase drum.
- Correct endpoint: inner edges of the upper and lower mire just kiss — they touch but do not overlap.
- Read the IOP: Read the number on the drum at the endpoint. Multiply by 10 to convert to mmHg (drum reads in units of 10 mmHg; e.g., drum reading of 1.5 = 15 mmHg).
- Retract the prism immediately after reading. Do not leave the prism in contact with the cornea.
- Take three readings per eye within the same session. If all three agree within 1 mmHg, average them. If any reading is more than 1–2 mmHg different from the others, take additional readings and use the median.
- Measure right eye first, then left eye. Document time of measurement (relevant for diurnal variation monitoring).
Mire Troubleshooting
| Mire Appearance | Cause | Correction |
|---|---|---|
| Very wide, bright mires | Excess fluorescein | Ask patient to blink; or lightly blot lower meniscus |
| Very thin, faint mires | Insufficient fluorescein | Add more fluorescein; re-apply strip to lower fornix |
| Mires blinking in and out | Patient blinking; unstable tear film | Measure immediately after a blink; encourage wide-open eye |
| Mires tilted / unequal height | Prism not aligned horizontally; significant astigmatism | Level the prism; set to 43° axis for astigmatism >3DC |
| Distorted / irregular mires | Irregular cornea (scar, KC), central staining | Average best-seen endpoints; consider Tono-Pen or iCare |
| Single mire visible | Prism touching only part of cornea; decentred | Recentre prism on corneal apex |
5. NCT Protocol
Principle
NCT uses a calibrated pulse of air to flatten (applanate) the cornea. An infrared optical monitoring system detects the exact moment of applanation — when the corneal surface is maximally flat — by measuring the reflectance of an aligned infrared beam. The time taken for the air pulse to flatten the cornea, or the pressure of the air jet at applanation, is converted to an IOP reading. No corneal contact is required, eliminating infection transmission and the need for topical anaesthesia.
Procedure
- Clean the chin rest and forehead bar with a disinfectant wipe before the patient is seated.
- Ask the patient to remove spectacles and contact lenses. Seat the patient comfortably with chin in the chin rest and forehead against the bar.
- Align the patient's eye with the nozzle aperture using the joystick and chin rest height adjustment. The crosshair alignment target should be centred on the corneal reflex seen through the monitor.
- Instruct the patient: "Look at the green dot/target inside the machine. The machine will puff air into your eye — try to keep your eye open and not blink."
- Once the corneal reflex is centred and the alignment indicators confirm correct position, the machine will fire the air puff automatically (auto-trigger mode) or upon pressing the trigger button.
- Take a minimum of 3 readings per eye. Most modern NCT instruments take 3 automatic readings and display the average. If readings are inconsistent (range >3 mmHg), take additional readings.
- Record the average IOP and note that NCT was used (relevant for clinical interpretation and comparison with GAT values).
Limitations of NCT
- Less accurate than GAT, especially at high IOP (>21 mmHg) — NCT tends to overestimate at high IOP.
- More affected by corneal biomechanical properties (corneal hysteresis) than GAT.
- Requires patient cooperation and alignment — difficult in patients with dense media opacity, nystagmus, or poor fixation.
- Air puff can be startling; reflex blink and squeezing may occur. Some patients find it uncomfortable.
- NCT is a screening tool. Any abnormal or borderline NCT reading should be confirmed with GAT before clinical management decisions are made.
6. Rebound Protocol
Principle
Rebound tonometry uses a lightweight, magnetised wire probe that is propelled towards the cornea by an electromagnetic coil. The probe makes momentary contact with the cornea and rebounds. The deceleration and rebound motion of the probe are analysed: a higher IOP results in faster deceleration and faster rebound. The device calculates IOP from the rebound parameters. No topical anaesthesia is required as the probe contact is so brief (milliseconds) that it is virtually imperceptible.
Procedure (iCare ic100 / ic200 / HOME)
- Load a new single-use probe into the device. Confirm the probe is securely loaded and the device is ready (green LED).
- Patient may be seated or standing. Ask patient to look straight ahead and keep the eye wide open.
- Hold the device horizontally, parallel to the floor. The probe tip should be pointing directly at the corneal apex at a distance of approximately 4–8 mm from the corneal surface.
- For the standard iCare ic100/ic200: rest the brow support (positioning device) against the patient's forehead to stabilise the device distance.
- Press the measurement button. The device fires the probe 6 times automatically and discards the highest and lowest readings, displaying the mean of the remaining 4 measurements.
- If the device displays an error (typically due to poor alignment or excessive eye movement), repeat the measurement sequence.
- Record the result. Note that iCare readings are generally comparable to GAT at normal IOP ranges, but may overestimate at very low IOP and underestimate at very high IOP in some studies.
Advantages & Limitations
Advantages
- No topical anaesthesia required
- No fluorescein required
- Patient-friendly, minimal discomfort
- Suitable for children and anxious patients
- Can be used in any position (including supine)
- Domiciliary use (iCare HOME — self-tonometry)
- Effective for corneas with surface irregularities
Limitations
- Single-use probe cost
- Less accurate than GAT at extremes of IOP
- Affected by CCT (thinner corneas may be underestimated)
- Requires patient to maintain fixation
- Not yet universally accepted as the clinical gold standard
7. Tono-Pen Protocol
Principle
The Tono-Pen is a handheld micro-applanation tonometer. A small, flat probe tip is applied to the cornea. A strain-gauge transducer within the probe detects the force required to applanate a very small area of the cornea. Multiple measurements are taken and averaged electronically. Because it applanates a much smaller area than GAT (1.02 mm vs 3.06 mm), it is less affected by corneal curvature but more affected by corneal rigidity.
Procedure
- Instil topical anaesthetic. A disposable latex cover (Ocu-Film tip cover) must be placed over the probe tip — this is essential for infection control and is required for each patient.
- Calibrate the Tono-Pen by holding it vertically downward and pressing the activation switch until a beep is heard and the display shows "Cal Good."
- Ask patient to look straight ahead. Hold the device like a pen, perpendicular to the corneal surface.
- Lightly and briefly touch the central cornea with the probe tip in a series of gentle taps — do not press. Each successful reading produces a single beep.
- The device requires 4 acceptable readings, after which it produces a double beep and displays the IOP with a confidence interval indicator (5%, 10%, 20% — lower percentage = more consistent readings).
- Accept readings with ≤5% or ≤10% confidence interval. Repeat if >20% as readings are inconsistent.
- Remove and dispose of the probe tip cover. Clean the probe with an alcohol wipe.
When to Use Tono-Pen
- Irregular or oedematous corneas: Corneal oedema, bullous keratopathy, Fuchs' endothelial dystrophy — GAT mires are distorted; Tono-Pen small tip can find a clear corneal area.
- Post-corneal transplant: Irregular topography makes GAT unreliable; Tono-Pen provides a usable estimate.
- Keratoconus: Steep apex and thin central cornea make GAT difficult. Tono-Pen can measure at the periphery to avoid the thin apex.
- Patients unable to use the slit lamp: Wheelchair-bound, head positioning problems, severe lid abnormalities — the handheld Tono-Pen provides flexibility.
- Paediatric examination under anaesthesia (EUA): Tono-Pen and Perkins are both appropriate for supine measurements under GA.
8. CCT & IOP Correction
Why CCT Matters
Goldmann applanation tonometry was calibrated for a cornea of average thickness — approximately 520 µm. When the cornea deviates from this value, GAT over- or underestimates the true IOP:
- Thin cornea (<520 µm): GAT underestimates IOP. A patient with thin corneas and an apparent IOP of 18 mmHg may have a true IOP of 21 mmHg or higher. This is clinically dangerous in glaucoma screening.
- Thick cornea (>520 µm): GAT overestimates IOP. A patient with thick corneas (e.g., 600 µm) may have an apparent IOP of 24 mmHg but a true IOP of only 19 mmHg — potentially avoiding unnecessary treatment.
The Ocular Hypertension Treatment Study (OHTS) demonstrated that CCT is an independent risk factor for glaucoma conversion. Patients with CCT <555 µm had a significantly higher risk of developing glaucoma than those with CCT >588 µm, irrespective of IOP level.
CCT Measurement — Pachymetry
- Ultrasound pachymetry (contact): Gold standard for CCT. Probe placed perpendicular to the central cornea after topical anaesthesia. Takes 5–10 readings; displays the average. Measurements accurate to ±5 µm.
- Optical coherence tomography (OCT): Non-contact; measures CCT as part of anterior segment imaging. Comparable accuracy to ultrasound.
- Scheimpflug imaging (Pentacam, Corvis ST): Provides full corneal thickness map, not just central CCT. Preferred for keratoconus screening and pre-refractive surgery assessment.
- Specular microscopy: Can estimate CCT but not the primary purpose of the instrument.
IOP Correction for CCT — Ehlers Correction Table
Multiple correction formulae exist (Ehlers, Shah, Doughty-Zaman). The most commonly used in clinical practice applies approximately +/−0.7 mmHg per 10 µm deviation from 520 µm(Doughty-Zaman). Note: these corrections are population-derived estimates and should be used as guides to clinical risk stratification, not as precise mathematical corrections.
| CCT (µm) | Approximate IOP Correction | Clinical Implication |
|---|---|---|
| 445 | Add ~5.3 mmHg | Very thin — significantly underestimated IOP; high glaucoma risk |
| 465 | Add ~3.9 mmHg | Thin — treat with lower IOP threshold |
| 485 | Add ~2.5 mmHg | Below average — lower clinical threshold |
| 505 | Add ~0.7 mmHg | Slightly thin — minor underestimation |
| 520 | No correction | Average CCT — GAT reading accepted as true IOP |
| 545 | Subtract ~1.8 mmHg | Above average — mild overestimation |
| 565 | Subtract ~3.2 mmHg | Thick — moderate overestimation |
| 585 | Subtract ~4.6 mmHg | Thick — IOP likely overestimated; reassure if no disc/field changes |
| 605 | Subtract ~6.0 mmHg | Very thick — likely significant overestimation |
Correction values based on Doughty MJ & Zaman ML (2000). Use as clinical guide only — individual corneal biomechanics (hysteresis, stiffness) vary independently of CCT and affect accuracy. Biomechanically corrected IOP (ORA or Corvis ST) reduces CCT-related error.
9. Interpreting IOP Results
Key Interpretation Principles
- IOP is not a diagnosis: Elevated IOP alone does not mean glaucoma. IOP must be interpreted alongside optic disc appearance, retinal nerve fibre layer (RNFL) thickness (OCT), visual fields, and angle anatomy (gonioscopy).
- Asymmetry between eyes: An IOP difference of ≥4 mmHg between the two eyes is clinically significant and should prompt further investigation even if both absolute values are within the normal range. Asymmetric IOP is a risk factor for glaucoma.
- Diurnal variation: IOP varies throughout the day — typically highest in the early morning. A single IOP measurement captures only one point in this cycle. In glaucoma suspects with borderline IOP, phased IOP measurements (measuring at different times of day) or 24-hour monitoring may be indicated.
- IOP fluctuation: Wide IOP fluctuation (>6 mmHg over time) is an independent risk factor for glaucoma progression, even when mean IOP is within target range.
- Target IOP: In established glaucoma, a "target IOP" is set — typically a 20–30% reduction from baseline, or an absolute target (often ≤18 mmHg for moderate glaucoma, ≤15 mmHg for advanced). Whether IOP is being consistently maintained at or below target is the key monitoring question.
- Normal tension glaucoma (NTG): IOP consistently ≤21 mmHg despite glaucomatous disc and field changes. NTG represents ~30–40% of glaucoma in European populations and up to 90% in some Asian populations. Vascular risk factors, nocturnal hypotension, and disc haemorrhages are particularly important in this group.
Acute Angle-Closure — Recognising the Emergency
Acute angle-closure glaucoma (AACG) presents with rapidly elevated IOP, typically >40–70 mmHg. It requires emergency treatment to prevent permanent optic nerve damage.
| Feature | Acute Angle Closure | POAG / OHT |
|---|---|---|
| IOP | >35–70 mmHg (acute) | 21–35 mmHg (chronic) |
| Symptoms | Severe eye pain, headache, nausea/vomiting, coloured haloes, blurred vision | Usually asymptomatic |
| Cornea | Hazy, oedematous (steamy) | Clear |
| Pupil | Mid-dilated, fixed, oval | Normal |
| Anterior chamber | Shallow; narrow angle | Normal depth; open angle |
| Management | Emergency — same-day ophthalmology referral; IV acetazolamide, pilocarpine, topical beta blocker, lying patient supine | Routine/urgent referral |
10. Management & Referral Thresholds
Ocular Hypertension (OHT)
- IOP consistently ≥22 mmHg on at least two separate occasions, with no glaucomatous optic disc changes and no visual field defects.
- Lifetime risk of converting to glaucoma: approximately 10% over 5 years (OHTS data). The 5-year risk can be calculated using the OHTS/EGPS risk calculator (IOP, CCT, disc size, age, pattern standard deviation).
- High-risk OHT features: IOP >26 mmHg, CCT <555 µm, large CDR, family history of glaucoma, age >65, African or Afro-Caribbean ethnicity.
- Low-risk OHT (NICE guidelines, UK): IOP 22–25 mmHg, CCT >590 µm, no disc changes, low OHTS risk score → observation only with annual review may be appropriate.
Glaucoma Suspect
- A patient with one or more risk factors for glaucoma but no definitive diagnosis: OHT, suspicious disc appearance (large CDR, disc haemorrhage, RNFL defect), suspicious visual field, family history of glaucoma, thin CCT, or narrow angles.
- Requires comprehensive glaucoma workup: IOP (multiple readings, both eyes), CCT, disc photography, OCT RNFL, gonioscopy, Humphrey visual fields (24-2 or 30-2).
- Frequency of monitoring depends on risk level. High-risk: 3–6 monthly. Moderate: 6–12 monthly.
Hypotony
- IOP <10 mmHg. May cause maculopathy, choroidal effusion, and hypotony maculopathy (retinal folds).
- Causes: Post-surgical wound leak, over-drainage bleb, cyclodialysis cleft, uveitis with ciliary body shutdown, trauma, excessive glaucoma medication effect.
- Requires prompt ophthalmology referral if symptomatic or associated with structural changes.
Management & Referral in Optometry Practice
Referral Thresholds & Pathways
| IOP Finding | Additional Features | Action | Timeframe |
|---|---|---|---|
| >35 mmHg with pain, haloes, hazy cornea | Possible acute angle closure | Emergency referral; call ophthalmology directly | Immediate (same hour) |
| ≥30 mmHg | Asymptomatic; any disc / CCT status | Urgent referral to ophthalmology / glaucoma service | Within 1 week |
| 26–29 mmHg | Suspicious disc or thin CCT | Refer to ophthalmology / glaucoma service | Within 2–4 weeks |
| 22–25 mmHg (OHT) | High-risk features (thin CCT, disc changes, family history) | Refer for full glaucoma evaluation | Within 4–6 weeks (routine) |
| 22–25 mmHg (OHT) | Low risk; CCT >590 µm; no disc changes; low OHTS risk | Monitor annually in community optometry (varies by country) | Annual review |
| Asymmetry ≥4 mmHg between eyes | Any IOP level | Full glaucoma workup; refer if confirmed on repeat | Routine–4 weeks |
| IOP <10 mmHg | Hypotony | Refer if new finding, symptomatic, or structural changes | Urgent if symptomatic |
Note: Referral thresholds vary by country and healthcare system (e.g., NICE guidelines UK, AAO PPP USA, RANZCO Australia/NZ, MOH guidelines Singapore/Malaysia). Clinicians should follow local/national guidelines applicable to their jurisdiction.
IOP-Lowering Treatment Overview
Prescribing IOP-lowering medication is within the scope of practice for therapeutically qualified optometrists in the UK, Australia, New Zealand, parts of the USA, Canada, and some other jurisdictions. In countries where prescribing is not within optometric scope, optometrists refer to ophthalmology for initiation of treatment.
| Drug Class | Example | Mechanism | IOP Reduction | Key Considerations |
|---|---|---|---|---|
| Prostaglandin analogues | Latanoprost 0.005%, bimatoprost 0.01%, travoprost 0.004% | ↑ uveoscleral outflow | 25–35% | First-line; once daily (nocturnal); can cause iris pigmentation, lash growth, periorbital fat atrophy |
| Beta-blockers | Timolol 0.25% / 0.5%, betaxolol 0.5% | ↓ aqueous production | 20–30% | Avoid in asthma, COPD, bradycardia, heart block. Betaxolol (selective β1) safer in pulmonary disease. |
| Carbonic anhydrase inhibitors (CAI) | Dorzolamide 2%, brinzolamide 1% (topical); acetazolamide (systemic) | ↓ aqueous production | 15–20% (topical); 30–40% (oral acetazolamide) | Avoid topical in sulphonamide allergy. Oral acetazolamide: metabolic acidosis, renal stones, hypokalaemia. |
| Alpha-2 agonists | Brimonidine 0.2% / 0.15%, apraclonidine 0.5% / 1% | ↓ aqueous production + ↑ uveoscleral outflow | 20–25% | Allergic conjunctivitis in ~10–20%. Avoid in children <2 years (CNS depression). Apraclonidine for short-term use only. |
| Rho kinase inhibitors | Netarsudil 0.02% (Rhopressa) | ↑ trabecular outflow + ↓ aqueous production | 15–20% | Conjunctival hyperaemia, corneal verticillata common. Once daily. |
| Fixed combinations | Cosopt (dorzolamide/timolol), Combigan (brimonidine/timolol), Ganfort (bimatoprost/timolol) | Combined mechanisms | 30–40% | Improves adherence; reduces preservative exposure vs. multiple drops |
Laser & Surgical Options (for Co-Management Reference)
- Selective Laser Trabeculoplasty (SLT): Non-invasive laser to the trabecular meshwork. Reduces IOP by 20–30%. Now recommended as first-line treatment in many guidelines (LiGHT trial evidence). Repeatable. Effect may diminish over 3–5 years.
- Laser Peripheral Iridotomy (LPI): Creates a hole in the peripheral iris to relieve pupil block in angle closure and narrow angles. Preventive treatment for fellow eye after acute angle closure.
- Trabeculectomy: Creates a drainage bleb allowing aqueous to bypass the trabecular meshwork. Gold standard surgical option for uncontrolled glaucoma. Risk of bleb-related complications.
- Minimally Invasive Glaucoma Surgery (MIGS): iStent inject, Hydrus, XEN gel stent, Preserflo. Lower surgical risk than trabeculectomy; increasingly used at time of cataract surgery in mild-moderate glaucoma.
11. Special Populations
Children
- Normal IOP in children: 10–21 mmHg (same range as adults; may be slightly lower in infants).
- GAT is difficult in uncooperative children. iCare (no anaesthetic) and NCT are preferred for awake children.
- Paediatric glaucoma (congenital, infantile, juvenile): presents with corneal enlargement (buphthalmos), Haab's striae (horizontal breaks in Descemet's membrane), corneal oedema, high myopia, photophobia, and epiphora. Urgent ophthalmology referral.
- Examination under anaesthesia (EUA) with Perkins or Tono-Pen used when awake assessment is impossible.
- Children's corneas are thinner and more elastic — IOP may be underestimated by GAT.
Post-Refractive Surgery (LASIK / PRK / SMILE)
- LASIK and PRK reduce CCT and alter corneal biomechanics. GAT will significantly underestimate IOP post-procedure — the degree of underestimation correlates with the amount of tissue removed.
- A correction of approximately +1 mmHg per 10 µm of stromal ablation is a rough guide, but not precise.
- Biomechanically corrected IOP (ORA's IOPcc or Corvis ST bIOP) is more reliable post-refractive surgery.
- Always document pre-operative IOP in refractive surgery candidates. Pre-existing glaucoma is a contraindication to LASIK.
- iCare rebound tonometry is also less affected by corneal ablation than GAT.
High Myopia & Keratoconus
- High myopia: Often associated with thin CCT and lower corneal hysteresis → GAT underestimates IOP. Annual IOP monitoring is particularly important as high myopia is itself a risk factor for glaucoma (especially NTG).
- Keratoconus: Very thin, irregular central cornea causes significant GAT underestimation. NCT is similarly unreliable. Tono-Pen (peripheral corneal measurement) or iCare are preferred. Biomechanically corrected IOP essential if glaucoma is suspected.
Steroid Use (Ocular & Systemic)
- Steroid-induced ocular hypertension: Topical, periocular, intravitreal, and systemic corticosteroids can raise IOP by reducing trabecular outflow facility. Risk is greatest with potent topical steroids (dexamethasone, prednisolone acetate) used long-term.
- IOP rise typically occurs 2–6 weeks after starting steroids. Steroid responders (genetic predisposition) may show IOP rises >10 mmHg. Patients with POAG and glaucoma suspects are at highest risk.
- Management: Discontinue or change to lower-potency steroid (fluorometholone, loteprednol) where clinically possible. Add IOP-lowering medication if IOP remains elevated. IOP usually returns to baseline 2–4 weeks after cessation.
- Any patient commenced on long-term topical steroids (e.g., post-LASIK, post-cataract, uveitis) should have IOP monitored at 4–6 weeks and regularly thereafter.
12. Clinical Pearls and Best Practices
Pearl #1: Calibrate Before Every Session
GAT calibration drift is common, especially in busy practices with frequent prism changes. A tonometer reading 2 mmHg high will cause unnecessary anxiety and inappropriate referrals. One reading 2 mmHg low may allow an IOP of 23 mmHg to be dismissed as 21 mmHg. Calibrate at the start of every clinical session — it takes 30 seconds.
Pearl #2: Not Too Much Fluorescein
Excess fluorescein is the most common source of GAT measurement error. Thick, wide, bright mires cause the examiner to neutralise them at a higher drum reading than the true IOP. Use a moistened fluorescein strip (touch to the lower fornix only), ask the patient to blink once, and proceed. If mires are still too wide, dab the lower lid margin gently with a tissue to absorb excess fluorescein before repeating.
Pearl #3: Astigmatism >3DC — Rotate the Prism
In patients with corneal astigmatism greater than 3DC, the mires will appear unequal in width and tilted. Set the prism to 43° (the red line aligns with the axis of the negative cylinder or 43° off the axis of the positive cylinder). This orientation bisects the two principal meridians and gives the most accurate average reading. Without this adjustment, the IOP can be erroneously over- or underestimated by up to 1–2 mmHg.
Pearl #4: Confirm Elevated NCT with GAT
NCT is a screening tool. Any NCT reading ≥22 mmHg should be confirmed with GAT at the same visit before any clinical management decision is made. NCT consistently overestimates at high IOP levels and is more susceptible to corneal rigidity variations. Do not refer a patient for suspected OHT based on NCT alone without GAT confirmation.
Pearl #5: Measure IOP Before Dilation
Always perform tonometry before instilling mydriatic drops, for two reasons: (1) dilation can occasionally precipitate angle closure in susceptible patients, and you want a pre-dilation baseline; (2) the van Herick assessment should also precede dilation to screen for narrow angles before proceeding. The sequence should always be: visual acuity → IOP → van Herick → dilation.
Pearl #6: Record Time of Measurement
IOP fluctuates diurnally by 3–6 mmHg in normal eyes and up to 10+ mmHg in glaucoma patients. An IOP of 18 mmHg at 4 pm may represent a peak of 26 mmHg at 7 am. Always document the time of IOP measurement alongside the reading. For patients on IOP-lowering treatment, recording whether the drop was instilled before the visit is also clinically important.
Pearl #7: CCT Changes Everything
A patient with an IOP of 23 mmHg and a CCT of 480 µm has a corrected IOP approaching 27 mmHg and a significantly elevated glaucoma risk. A patient with an IOP of 25 mmHg and a CCT of 610 µm likely has a true IOP of ~19 mmHg and may not require treatment. CCT measurement should be performed in every new glaucoma suspect. Never manage OHT without knowing the CCT.
Pearl #8: IOP Alone Does Not Diagnose Glaucoma
Up to 40% of patients with glaucoma have an IOP within the statistically normal range (normal tension glaucoma). Conversely, many patients with IOP >21 mmHg will never develop glaucoma (OHT). Glaucoma diagnosis requires evidence of optic nerve damage (disc changes, RNFL loss on OCT) or functional loss (visual field defects) — not IOP alone. IOP is a risk factor and treatment target, not a diagnostic criterion.
Pearl #9: Steroids Raise IOP — Always Ask
In any patient with unexplained elevated IOP, ask specifically about steroid use: topical eye drops (including those prescribed by another clinician), nasal sprays, skin creams (especially if applied near the eye), inhaled steroids, and systemic steroids. Steroid responders may experience IOP rises of >10–15 mmHg. Steroid-induced OHT is easily missed if the history is not specifically elicited.
Pearl #10: Asymmetric IOP is a Red Flag
An IOP of 16 mmHg in both eyes is entirely normal. An IOP of 16 mmHg in the right eye and 21 mmHg in the left eye requires investigation even though both readings are within the “normal” range. A difference of ≥4 mmHg between the two eyes is associated with increased glaucoma risk and may indicate unilateral trabecular dysfunction, Fuchs' heterochromic cyclitis, pseudoexfoliation syndrome, or unilateral angle closure.
Golden Rule of Tonometry
“Measure IOP accurately, interpret it in context, and never manage it in isolation.”The value of tonometry lies not in the number alone but in how it is combined with disc assessment, OCT, visual fields, CCT, angle anatomy, and the patient's systemic risk profile. An optometrist who obtains a precise IOP reading and documents it with its context — the technique, time, patient cooperation, CCT, and clinical correlates — is practising glaucoma care at the highest standard. That diligence is what prevents blindness.
Quick Reference Protocol
- Measure IOP before dilation and after contact lens removal.
- Use GAT as the reference standard and confirm elevated NCT findings with GAT.
- Take multiple readings per eye and document method, time, and reliability.
- Interpret IOP with CCT, optic disc, OCT RNFL, visual fields, and angle findings.
- Escalate urgently for very high IOP, acute symptoms, or suspected angle closure.
Documentation and Communication
Document
- IOP values for each eye, measurement method, and number of readings.
- Time of measurement, patient cooperation, and any artefacts or constraints.
- Related findings: CCT, optic nerve/RNFL status, field data, and angle risk.
Communicate
- Explain that IOP is a risk marker interpreted in full clinical context.
- Provide clear follow-up timing and referral urgency when thresholds are met.
- Record safety-net advice for pain, haloes, nausea, or sudden vision change.
References
- Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach, 8th ed. Edinburgh: Elsevier; 2016.
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911.
- Goldmann H, Schmidt T. Über Applanationstonometrie. Ophthalmologica. 1957;134(4):221–242.
- Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714–720.
- Brandt JD, Beiser JA, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004;138(5):717–722.
- Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44(5):367–408.
- Shah S, Chatterjee A, Mathai M, et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology. 1999;106(11):2154–2160.
- Tonnu PA, Ho T, Newson T, et al. The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, non-contact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry. Br J Ophthalmol. 2005;89(7):851–854.
- Munkwitz S, Elkarmouty A, Hoffmann EM, Pfeiffer N, Thieme H. Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer over a wide IOP range. Graefes Arch Clin Exp Ophthalmol. 2008;246(6):875–879.
- Medeiros FA, Weinreb RN. Evaluation of the influence of corneal biomechanical properties on intraocular pressure measurements using the ocular response analyzer. J Glaucoma. 2006;15(5):364–370.
- Luce DA. Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg. 2005;31(1):156–162.
- Heijl A, Leske MC, Bengtsson B, et al; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279.
- Gazzard G, Konstantakopoulou E, Garway-Heath D, et al; LiGHT Trial Study Group. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505–1516.
- NICE. Glaucoma: diagnosis and management. NICE guideline NG81. London: National Institute for Health and Care Excellence; 2022. Available at: https://www.nice.org.uk/guidance/ng81
- American Academy of Ophthalmology Preferred Practice Pattern Glaucoma Panel. Primary Open-Angle Glaucoma Preferred Practice Pattern. San Francisco: AAO; 2020.
- Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48–56.
- Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol. 1963;70:482–491.
- Iester M, Mermoud A, Achache F, Roy S. New Tonopen XL: comparison with the Goldmann tonometer. Eye (Lond). 2001;15(Pt 1):52–58.
- College of Optometrists. Clinical Management Guidelines — Ocular Hypertension and Glaucoma. London: College of Optometrists; 2024. Available at: https://www.college-optometrists.org/clinical-guidance
- RANZCO. Referral pathways and co-management guidelines for glaucoma and ocular hypertension. Sydney: Royal Australian and New Zealand College of Ophthalmologists; 2021.